Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

Nov 22, 2013

30071_dirs_2013-11-22_0d568400-b0c3-4e64-9366-6d9a996aeb91.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-11-20

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-20 ResMed Common Stock S 7700 $51.00 Disposed 102202.2572 Direct
2013-11-20 ResMed Common Stock S 500 $51.048 Disposed 101702.2572 Direct
2013-11-20 ResMed Common Stock S 6300 $51.12 Disposed 95402.2572 Direct
2013-11-20 ResMed Common Stock S 500 $51.13 Disposed 94902.2572 Direct

Footnotes

F1: Includes 190.0972 shares of stock purchased on October 31, 2013 pursuant to the ResMed Employee Stock Purchase Program.